David Li-Kroeger

Dr. David Li-Kroeger

orcid

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 June 2022
Verified
Book Chapter
Closed access
PDF file
SYSheng-An Yang
Sheng-An Yang
JSJose L. Salazar
Jose L. Salazar
DLDavid Li-Kroeger
David Li-Kroeger
SHINYA YAMAMOTOSHINYA YAMAMOTO
SHINYA YAMAMOTO

1 October 2019 in bioRxiv
Verified
Preprint
Open access
PDF file
HYHui Ye
Hui Ye
SOShamsideen Ojelade
Shamsideen Ojelade
DLDavid Li-Kroeger
David Li-Kroeger
ZZZhongyuan Zuo
Zhongyuan Zuo
LWLiping Wang
Liping Wang
JSJoshua M. Shulman
Joshua M. Shulman
Retromer, including Vps35, Vps26, and Vps29, is a protein complex responsible for recycling proteins within the endolysosomal pathway. Although implicated in both Parkinson’s and Alzheimer’s disease, our understanding of retromer function in the adult brain remains limited, in part because Vps35 and Vps26 are essential for development. In Drosophila , we find that Vps29 is dispensable for embryogenesis but required for retromer function in aging adults, including for synaptic transmission, survival, and locomotion. Unexpectedly, in Vps29 mutants, Vps35 and Vps26 proteins are normally expressed and associated, but retromer is mislocalized from neuropil to soma with the Rab7 GTPase. Further, Vps29 phenotypes are suppressed by reducing Rab7 or overexpressing the GTPase activating protein, TBC1D5. With aging, retromer insufficiency triggers progressive endolysosomal dysfunction, with ultrastructural evidence of impaired substrate clearance and lysosomal stress. Our results reveal the role of Vps29 in retromer localization and function, highlighting requirements for brain homeostasis in aging. Impact Statement: Vps29 promotes retromer localization in the adult Drosophila brain, engaging Rab7 and TBC1D5, and its loss triggers age-dependent neuronal impairments in endolysosomal trafficking and synaptic transmission.

1 December 2024 in Alzheimer's & Dementia
Verified
Journal Article
Open access
DLDavid Li-Kroeger
David Li-Kroeger
IAIsmael Al‐Ramahi
Ismael Al‐Ramahi
NSNathaniel Smith
Nathaniel Smith
AMAditi Marella
Aditi Marella
BABismark K Amoh
Bismark K Amoh
JSJoshua M Shulman
Joshua M Shulman
Background: Alzheimer’s disease (AD) has a complex etiology where insults in multiple pathways conspire to disrupt neuronal function, yet molecular changes underlying AD remain poorly understood. Previously, we performed mass‐spectrometry on post‐mortem human brain tissue to identify >40 protein co‐expression modules correlated to AD pathological and clinical traits. Module 42 has the strongest correlation to AD pathology and consists of 32 proteins including SMOC1, a predicted driver of network behavior and potential biomarker for AD. SMOC1 is a matrisomal protein with conserved roles in modulating TGF‐Beta and wnt signaling during development, yet remains unstudied in the brain.Methods: We evaluate M42 using a high‐throughput robotic screening platform and video assisted software, enabling quantitative assessments of neurological function to identify proteins that modify Aβ‐ or tau‐induced neurodegeneration. We then focus on dSMOC1 using Drosophila genetics and cell biological approaches to determine its role in the brain. Finally, we use Mass Spectrometry to identify protein changes in the brains of dSMOC1‐/‐ flies.Results: Our screening assay identified 20 genes from M42 that modify tau toxicity and 5 for Aβ, including dSMOC1 and components of Wnt and TGF‐β signaling pathways. We find dSMOC1‐/‐ null flies suffer severely decreased survival and climbing defects upon aging. In the brain, dSMOC1 expression occurs primarily in glial cells while protein localizes around neuronal cell bodies, consistent with its role as a matrisomal protein. We show alteration of glypican levels in dSMOC1‐/‐ brains. Glypicans modulate Wnt and TGF‐β signaling further supporting a role connecting M42 in AD biology. Finally, we used mass spectrometry to determine protein changes in brains of dSMOC1‐/‐ flies and found perturbations in ECM/receptor interactions, proteostasis, KREBs/TCA cycle, and oxidative phosphorylation. Additional data suggests an age dependent shift from oxidative phosphorylation to glycolysis may compensate for reduced ATP levels in dSMOC1‐/‐ flies.Conclusion: The M42 protein module contains multiple proteins with links to AD. Multiple M42 proteins interact with specific AD triggers including SMOC1, wnt and TGF‐β signaling components. The genetics, proteomics, and cell biological data combine to support a mechanistic hypothesis where changes in SMOC1 levels disrupt critical signaling pathways leading to disruptions in metabolism affecting neuronal function.

23 December 2025 in Alzheimer's & Dementia
Verified
Journal Article
Open access
DLDavid Li-Kroeger
David Li-Kroeger
IAIsmael Al‐Ramahi
Ismael Al‐Ramahi
NSNathaniel Smith
Nathaniel Smith
AMAditi Marella
Aditi Marella
BABismark K Amoh
Bismark K Amoh
JSJoshua M Shulman
Joshua M Shulman
Background: Alzheimer's disease (AD) has a complex etiology where insults in multiple pathways collude to disrupt neuronal function, yet the molecular changes underlying AD remain poorly understood. To identify changes associated with AD, we previously performed mass‐spectrometry on post‐mortem brain tissue and identified protein co‐expression networks correlated to AD pathological and clinical traits. The network most strongly correlated with AD pathology is enriched in components of the matrisome and includes multiple signaling pathways, Aß, APOE, and SMOC1, a predicted driver of network behavior. SMOC1 is a matrisomal protein with conserved roles in modulating signaling during development, yet its role in the adult brain remains unstudied. Methods: We evaluate the SMOC1 protein network using the powerful genetics of Drosophila melanogaster to determine its role in the brain and uncover links to specific triggers of AD: Amyloid‐Beta (Aβ) and tau. We use a high‐throughput robotic screening platform and video assisted software enabling quantitative assessments of neurological function to identify proteins modifying Aβ‐ or tau‐induced neurodegeneration. We use Mass‐Spectrometry to identify protein changes in the brains of flies with loss‐of‐function mutations in dSMOC1 and genetics, cell biology, and immunofluorescence to characterize dSMOC1 function. Results: We identified 25 genes from the SMOC1 network with robust evidence of interactions with either tau or Aβ toxicity in fly AD models. Consistent with its central, interconnected position within the network, dSMOC1 shows genetic interactions with at least 8 other network genes. dSMOC1 is expressed in the brain by many glia and some neurons, however, dSMOC1 protein is mainly localized around neuronal cell bodies. dSMOC1 ‐/‐ mutant flies have severe locomotor defects, reduced survival, and show cell‐type specific changes in glypican expression, potentially linking the network to Wnt and TGF‐β signaling. Finally, proteomics from dSMOC1 ‐/‐ fly heads show perturbations in ECM/Receptor interactions, metabolism, signaling, and proteostasis Conclusion: The SMOC1 protein network contains multiple proteins with links to AD, and dSMOC1 is likely a key driver of network function. Together, the genetics and proteomics data show that dSMOC1 is an important regulator of extracellular matrix function in the brain and suggest a mechanistic hypothesis where dSMOC1 fine‐tunes multiple signaling modalities to regulate cellular homeostasis.